Compositions, devices, kits and methods for attaching stent-containing medical devices to tissue
US-2015374516-A1 · Dec 31, 2015 · US
US9814608B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9814608-B2 |
| Application number | US-201414227501-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2014 |
| Priority date | Jul 14, 2011 |
| Publication date | Nov 14, 2017 |
| Grant date | Nov 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A stent that includes a plurality of quill filaments. Each quill filament includes filament material, a surface, and a plurality of quills. Each quill has a tip, a body, and a base where the body extends from the base to the tip. The quill filaments can be interwoven to form the stent or the quill filaments can be engaged to the framework of a stent.
Opening claim text (preview).
The invention claimed is: 1. An interwoven stent comprising a middle stent region between two end stent regions and quills oriented towards a first stent end, wherein the middle stent region is quill free, each quill integral with a quill filament, the stent comprising a plurality of quill filaments, wherein only the two end stent regions have quills, and wherein each quill filament comprises a first zone, a second zone, and a third zone, the second zone connecting the first and third zones, each quill filament having quills only in the first and third zones. 2. The stent of claim 1 , the quill filaments having a same orientation when incorporated into the stent. 3. The stent of claim 1 , wherein quills in the first and third zones face a first filament end. 4. The stent of claim 1 , the stent further comprising quills oriented towards a second stent end, wherein the quills of the first zone face a first filament end, and the quills of the third zone face a second filament end. 5. The stent of claim 1 , the stent further comprising a cover, wherein the quills engage the cover. 6. A stent comprising interwoven quill filaments, each quill filament having quills, the quills including first quills oriented towards a first filament end, and second quills oriented towards a second filament end, the quills alternating between first quills and second quills, the stent having quills oriented towards each stent end, wherein the interweaving of quill filaments defines successive intersections between quill filaments, and wherein when a quill selected from the first quills or the second quills is present between successive intersections of quill filaments only one quill is present between successive intersections of quill filaments. 7. The stent of claim 6 , the stent comprising a middle stent region between two end stent regions, the two end stent regions having a larger diameter than the middle stent region. 8. The stent of claim 6 , the stent further comprising a cover, wherein the quills engage the cover. 9. The stent of claim 6 , the stent having no looped ends.
Means for introducing or releasing pharmaceutical products into the body · CPC title
having means for fixation to the vessel wall, e.g. barbs · CPC title
differing in diameter · CPC title
using shape memory or superelastic materials, e.g. nitinol · CPC title
with sharp anchoring protrusions, e.g. barbs, pins, spikes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.